Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial [Peripheral Vascular Disease]

Conclusions— Three-year results demonstrate a durable and superior treatment effect among patients treated with DCB versus standard PTA, with significantly higher primary patency and lower clinically driven target lesion revascularization, resulting in similar functional improvements with reduced need for repeat interventions. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifiers: NCT01175850 for IN.PACT SFA phase I in the European Union and NCT01566461 for IN.PACT SFA phase II in the United States.

http://circinterventions.ahajournals.org/cgi/content/short/11/1/e005891?rss=1

Source: Circulation: Cardiovascular Interventions - January 11, 2018 Category: Cardiology Authors: Schneider, P. A., Laird, J. R., Tepe, G., Brodmann, M., Zeller, T., Scheinert, D., Metzger, C., Micari, A., Sachar, R., Jaff, M. R., Wang, H., Hasenbank, M. S., Krishnan, P., for the IN.PACT SFA Trial Investigators Tags: Peripheral Vascular Disease Source Type: research